Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Depression during multiple sclerosis relapse: relation to disability and relapse severity.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Relapse of neuromyelitis optica during pregnancy-Treatment options and literature review.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Recent advances and future challenges in the genetics of multiple sclerosis.
Interactions of innate and adaptive immunity in brain development and function.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
Central motor conduction time.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
Inhibitors of myelination: ECM changes, CSPGs and PTPs.
Fatigue in multiple sclerosis is not due to sleep apnoea.
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Diversity Matters: A Revised Guide to Myelination.

Pages